This is surprising, because the CPHD and IGHD patients in the Dutch cohort have the same phenotype as patients from other countries, where mutations in PROP1, POU1F1 and HESX1 are much more prevalent. Here, PROP1 is linked to isolated congenital growth hormone deficiency.